For the patient. Alloimmunization: one risk of treating sickle cell disease
- PMID: 20506598
Item in Clipboard
For the patient. Alloimmunization: one risk of treating sickle cell disease
Ethn Dis.
2010 Spring.
No abstract available
Original report in
-
Alloimmunization and clinical profile of sickle cell disease patients from Salvador-Brazil.Ethn Dis. 2010 Spring;20(2):136-41. Ethn Dis. 2010. PMID: 20503893
Similar articles
-
Immunoregulatory networks in sickle cell alloimmunization.Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):457-461. doi: 10.1182/asheducation-2016.1.457. Hematology Am Soc Hematol Educ Program. 2016. PMID: 27913516 Free PMC article. Review.
-
HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease.Pediatr Blood Cancer. 2010 Apr;54(4):552-8. doi: 10.1002/pbc.22327. Pediatr Blood Cancer. 2010. PMID: 19890898 Free PMC article.
-
Red blood cell alloimmunization in sickle cell anemia: more questions than answers?Transfusion. 2012 Feb;52(2):214-6. doi: 10.1111/j.1537-2995.2011.03502.x. Transfusion. 2012. PMID: 22239207 No abstract available.
-
Red cell transfusions for patients with sickle cell disease: do we have more to learn?Pediatr Blood Cancer. 2010 Apr;54(4):499-500. doi: 10.1002/pbc.22353. Pediatr Blood Cancer. 2010. PMID: 19998466 Review. No abstract available.
-
Red blood cell alloimmunization: lessons from sickle cell disease.Transfusion. 2013 Apr;53(4):692-5. doi: 10.1111/trf.12146. Transfusion. 2013. PMID: 23565994 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical